Multi-institutional phase II study of concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for locally advanced uterine cervical cancer.
Not Applicable
- Conditions
- ocally advanced cervical cancer
- Registration Number
- JPRN-UMIN000001042
- Lead Sponsor
- Japanese Gynecologic Oncology Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with stump cancer 2) Patients with active infections 3) Patients with hydronephrosis 4) Patients with unstable angina, history of cardiac infarction within 6 months, or arrhythmia that requires medical treatment 5) Patients with serious complications 6) Patients who previously received pelvic radiotherapy 7) Patients with active concomitant malignancy 8) Patients who have undergone surgical staging 9) Patients with psychiatric illness that would prevent informed consent 10) Patients during pregnancy or breast-feeding, or unwilling to the use of contraception 11)Patients who are inappropriate to enter this study with any safety reasons, judged by the treating physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Progression-free survival
- Secondary Outcome Measures
Name Time Method Feasibility, Toxicity, Tumor response, Overall survival